You are currently viewing a new version of our website. To view the old version click .

Inflammation and Atherosclerosis: Emerging Mechanisms, Biomarkers and Therapeutic Opportunities

Special Issue Information

Dear Colleagues,

In recent years, growing evidence has established inflammation as a central driver of atherosclerotic plaque initiation, progression, and destabilisation. Advances in molecular and imaging technologies have unveiled complex interactions between immune, vascular, and metabolic pathways that govern plaque vulnerability and contribute to acute cardiovascular events. At the same time, the identification of novel inflammatory biomarkers and signalling mediators is opening new avenues for the development of diagnostic tools and targeted therapeutic strategies.

In this Special Issue on inflammation and atherosclerosis, we aim to highlight recent discoveries in the field, encompassing fundamental mechanistic insights as well as translational and clinical advances. Topics will include inflammatory pathways involved in plaque destabilisation, emerging biomarkers for risk stratification, innovative imaging approaches, and novel anti-inflammatory or immunomodulatory interventions.

We welcome original research articles, perspectives, and comprehensive review papers that advance understanding of inflammation-driven atherosclerosis and promote the development of strategies to predict and prevent plaque rupture and its clinical consequences.

Dr. Victoria McGilligan
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • atherosclerosis
  • inflammation
  • inflammatory biomarkers
  • anti-inflammatory therapies
  • plaque vulnerability
  • diagnostics and prognostics

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cells - ISSN 2073-4409